Financial & competing interests disclosure
Philip Bath is Stroke Association Professor of Stroke Medicine. Philip Bath was a member of the SCAST Trial Steering Committee and received travel grants from AstraZeneca to attend committee meetings. He is Chief Investigator of ENOS, and was on the executive or steering committees of INTERACT and PRoFESS. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.